期刊文献+

尿细胞角蛋白检测与尿脱落细胞学检查在膀胱癌诊断中的价值 被引量:1

Comparison between urinary cytokeratin test and voided urine cytology for detection of bladder cancer
下载PDF
导出
摘要 目的:探讨尿细胞角蛋白检测与尿脱落细胞学检查在膀胱移行细胞癌诊断中的价值。方法:136例怀疑膀胱癌者,进行尿细胞角蛋白8和18的含量(UBC值)。检测与尿细胞学检查,其中87例经组织学证实为膀胱移行细胞癌。比较两者诊断膀胱癌的敏感性和特异性。结果:尿细胞角蛋白的敏感性为70.1%,特异性为73.3%;尿细胞学的敏感性为42.5%,特异性为83.7%。尿细胞角蛋白在膀胱癌不同分级和分期中的敏感性优于尿细胞学(P<0.05)。结论:尿细胞角蛋白的检测在早期诊断膀胱癌方面优于尿细胞学检查,可作为膀胱癌的早期检测指标。 Purpose: To compare the sensitivity and specificity of urinary cytokeratin test with voided urine cytology in detection of bladder cancer and to evaluate their clinical values. Methods: For 136 patients suspected to have bladder cancer urinary concentrations cvtokeratin 8 and 18 and cytology were eonducted in the same voided urine samples. Of them 87 patients with bladder transitional cell carcinoma were confirmed histologically The sensitivity and specificity of urinary cytokeratin and urine cytology were aualvzed. 49 patieuts without bladder cancer were selected as control. Results: The overall sensitivity aud specificity of urinary cvtokeratin test were 70.1% and 73.3%, respetively , those of urine cytology were 42.5% and 83.7%. respectively, there was no significant difference between the specificity of urine cytology and that of urinary cvtokeratin test ; however, urinary cvtokeratin was significantly more sensitive than urine cytology in detection of any stages and grades of bladder cancer ( P 〈 0. 05). Conclusions: The urinary eytokeratin test is superior to voided urine cytology in sensitivity and it is a potent adjunctive parameter to cystoscopy for early detection and monitoring of bladder cancer.
出处 《中国癌症杂志》 CAS CSCD 2005年第6期575-576,共2页 China Oncology
关键词 膀胱肿瘤 角蛋白 尿细胞学 诊断方法 bladder cancer keratin urine cytology diagnosis
  • 相关文献

参考文献4

  • 1Silen A,Rizvi SSH ,Letocha H,et al.Evaluation of the UBC test in the urine of healthy individuals ,patients with benign disorders and urine bladder cancer [J] .Oncol Rep,2000,7 (6):1269-1274.
  • 2Mian C,Lodde M,Haitel A,et al.Comparison of the monoclonal UBS-ELISA test and the NMP22 ELISA test for the detection of urothelial cell carcinoma of the bladder [J].Urology,2000,55(2) :223-226.
  • 3李涛,陈梓甫,林成栋,高祥勋,詹汉雄,陈文榜,何延瑜,詹天棋,张延榕.尿细胞角蛋白检测在诊断尿路移行细胞癌中的价值[J].中华泌尿外科杂志,2003,24(11):774-776. 被引量:3
  • 4Sanchez-Carbayo M,Herrero E,Megias J,et al .An initial evaluation of the diagnostic performance of the new urinary bladder cancer antigen test as a tumor marker for transitional cell carcinoma of the bladder [J].Urology,1999,161(4) :1110-1115.

二级参考文献4

  • 1Silen A, Rizvi SSH, Letocha H, et al. Evaluation of the UBC test in the urine of healthy individuals, patients with benign disorders and urinary bladder cancer. Oneol Reports, 2000,7 : 1269 - 1274.
  • 2Mian C, Lodde M, Haitel A,et al. Comparison of the monoclonal UBCELISA test and the NMP 22 ELISA test for the detection of urothelial cell carcinoma of the bladder. Urology, 2000,55:223-226.
  • 3Sanchez-Carbayo M, Herrero E, Megias J, et al. An initial evaluation of the diagnostic performance of the new urinary bladder cancer antigen test as a tumor marker for transitional cell carcinoma of the bladder. J Urol, 1999,161 : 1110-1115.
  • 4Sumi S, Arai K, Kitahara S, et al. Preliminary report of the clinical performance of a new urinary bladder cancer antigen test : comparison to voided urine cytology in the detection of transitional cell carcinoma of the bladder. Clin Chim Acta,2000,296 : 111-120.

共引文献2

同被引文献31

  • 1张绍谨,刘红耀.尿膀胱癌抗原、核基质蛋白22和透明质酸诊断膀胱癌的临床价值[J].中华临床医师杂志(电子版),2011,5(24):7202-7205. 被引量:15
  • 2李涛,何延瑜,王颖,陈梓甫,张延榕.膀胱癌抗原在膀胱移行细胞癌诊断中的价值[J].实用肿瘤学杂志,2005,19(1):18-21. 被引量:4
  • 3Jemal A, Bray F, Center M M, et al. Global cancer statisties[J]. CA Cancer J Clin, 2011, 61(2) : 69-90.
  • 4Donat S M. Evaluation and follow- up strategies for superficial bladder caneer[J]. Urol Clin North Am, 2003, 30(4): 765-776.
  • 5Dalbagni G, Herr H W. Current use and questions concerning intravesieal bladder cancer group for super- ficial bladder eaneer[J]. Urol Clin North Am, 2000, 27(1): 137-146.
  • 6Whiting P, Rutjes A W, Reitsma J B, et al. The de- velopment of QUADAS: a tool for the quality assess- ment of studies of diagnostic accuracy included in sys- tematic reviews[J]. BMC Med Res Methodol, 2003,3: 25.
  • 7Jadad A R, Moore R A, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary[J]? Control Clin Trials, 1996, 17 (1): 1-12.
  • 8Sil6n , Rizvi SS, Letocha H, et al. Evaluation of the UBC test in the urine of healthy individuals, patients with benign disorders and urinary bladder cancer[J]. Oncol Rep, 2000, 7(6): 1269-1274.
  • 9Sumi S, Arai K, Kitahara S, et al. Preliminary report of the clinical performance of a new urinary bladder cancer antigen test: comparison to voided urine cytolo- gy in the detection of transitional cell carcinoma of the bladder[J]. Clin Chim Acta, 2000, 296(1-2) : 111- 120.
  • 10Heicappell R, Schostak M, Miiller M, et al. Evalua- tion of urinary bladder cancer antigen as a marker for diagnosis of transitional cell carcinoma of the urinary bladder[J]. Scand J Clin Lab Invest, 2000, 60(4): 275 -282.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部